Rocket Lab's stock has fallen 25% over three months due to a delay in the Neutron rocket's first launch, now pushed to 2027 from late 2026. Despite this setback, Wall Street analysts remain optimistic, citing a strong $2.36 billion backlog, a major defense contract, and the upcoming Iridium acquisition. The consensus price target suggests nearly 94% upside, with some analysts forecasting up to 147% gains if Neutron launches successfully and revenue targets are met. The company's improving margins and defense sector involvement add to the positive outlook, though further delays could increase risks.
Rocket Lab USA Inc (RKLB) trades at USD 52.62 on Pluang as of Oct 26, 2026 20:01 WIB, holding a market cap of $33.63 billion. Despite the recent 25% drop over three months mentioned in the news, the stock shows resilience with a slight 0.04% gain on the day. The company’s enterprise value stands at $31.46 billion, reflecting its significant presence in the industrials sector during this period.
Rocket Lab's stock has fallen nearly 30% in a month following a delay in the Neutron rocket launch due to a defect in its carbon-composite tank. Despite this, the company's backlog surged 137% year over year to $2.36 billion, driven by defense contra...
Rocket Lab successfully launched its 98th Electron rocket mission, delivering three HawkEye 360 satellites into low Earth orbit. These satellites operate in formation to collect radio frequency data for maritime tracking, GNSS jamming detection, and ...
Rocket Lab Corporation (RKLB) has been upgraded to a Buy rating due to its structural advantage of owning both launch and satellite assets, further boosted by its acquisition of Iridium, which is expected to bring immediate positive EBITDA. Meanwhile...
Space stocks are experiencing a sharper decline than the broader tech sector, with SpaceX, AST SpaceMobile, and Rocket Lab shares falling 6%, 6%, and 5% respectively. This drop follows a recent rally after SpaceX reported its first profitable quarter...
